Skip to main content

Smith & Nephew Failed To Toss Synergy Hip Replacement Case

Smith & Nephew Failed To Toss Synergy Hip Replacement Case

Smith & Nephew Failed To Toss Synergy Hip Replacement Case

Introduction

In an order issued on February 6, Arkansas federal Judge Timothy Brooks denied summary judgment request filed by Smith &  Nephew in a lawsuit involving its Synergy Stem artificial hip, finding questions of fact whether the hip system had a manufacturing and/ or compositional defect at the time it was implanted.

Judge Timothy Brooks refused to exclude the testimony provided by the plaintiff's expert witnesses and stated that the expert witnesses were qualified enough to have an opinion on metallurgy and damages. The plaintiff, John Myatt, underwent a hip replacement surgery in 2004, following a fatal car accident, and he was implanted with Smith & Nephew's Synergy Stem.

Smith & Nephew manufactures several hip replacement systems meant to increase mobility and improve durability. However, the company's metal-on-metal implants were linked to serious complications like metallosis. The company faces more than 500 hip implant lawsuits which are consolidated into federal litigation. Similar lawsuits are filed against other hip device manufacturers in the U.S. involving defendants Zimmer, Stryker, Biomet, Wright, and DePuy Synthes.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Talcum Powder Cancer Settlement Talks Begin Sept. 4

Categories: Talcum

Representatives of Johnson & Johnson (J&J) and attorneys for tens of thousands of plaintiffs involved in talcum powder lawsuits are scheduled to meet in September 2025 in an…

Tepezza Hearing Loss Trials Delayed Until Aug 2026

Categories: Tepezza

A series of Tepezza hearing loss lawsuits, which were expected to go before juries next year, will now be delayed. The U.S. District Judge overseeing the multidistrict…

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!